GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sipai Health Technology Co Ltd (HKSE:00314) » Definitions » 3-Year FCF Growth Rate

Sipai Health Technology Co (HKSE:00314) 3-Year FCF Growth Rate : 0.00% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Sipai Health Technology Co 3-Year FCF Growth Rate?

Sipai Health Technology Co's Free Cash Flow per Share for the six months ended in Dec. 2023 was HK$0.02.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Competitive Comparison of Sipai Health Technology Co's 3-Year FCF Growth Rate

For the Medical Distribution subindustry, Sipai Health Technology Co's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sipai Health Technology Co's 3-Year FCF Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sipai Health Technology Co's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Sipai Health Technology Co's 3-Year FCF Growth Rate falls into.



Sipai Health Technology Co 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Sipai Health Technology Co  (HKSE:00314) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Sipai Health Technology Co 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Sipai Health Technology Co's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Sipai Health Technology Co (HKSE:00314) Business Description

Traded in Other Exchanges
Address
No. 1888, Caoyang Road, 7/F, Building 3, Xingguangyao Plaza, Putuo District, Shanghai, CHN
Sipai Health Technology Co Ltd is a medical technology and health management company in China. It has three reportable operating segments: Specialty Pharmacy Business - operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Health Insurance Services Business - rendering insurance brokerage services to insurance companies. The company generates key revenue from Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.
Executives
Chang Jimmy Ching-hsin 2201 Interest of corporation controlled by you
Jeneration Group Limited 2201 Interest of corporation controlled by you
Leung Catherine Ho Yan 2202 Interest of your spouse
Purple Panther 2201 Interest of corporation controlled by you
Ma Xuguang 2501 Other
Li Ji 2501 Other
Wise Approach Investments Limited 2101 Beneficial owner
Ark Trust (hong Kong) Limited 2301 Trustee
Jpmorgan Chase & Co. 2502 Approved lending agent
Lucky Seven Healthcare Co., Ltd. 2101 Beneficial owner
Simul International Holdings Limited 2201 Interest of corporation controlled by you
Oriental Power Holdings Limited
Nasturtium Investment Limited
Tencent Mobility Limited
Tencent Holdings Limited

Sipai Health Technology Co (HKSE:00314) Headlines

No Headlines